Related Experiment Video

Updated: Jun 13, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

T-Cell Lymphoma Associated with CAR-T Cell Therapy: A Bayesian Disproportionality Analysis of a National Database

Connor Frey1

  • 1Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Transplantation and Cellular Therapy
|June 11, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Bayesian AnalysisCAR-T Cell TherapyCiltacabtagene AutoleucelSecondary Primary MalignancyT-Cell Lymphoma

More Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.